Management of Pandu Roga (Iron Deficiency Anaemia) in Children with Dadimadi Ghrita and Mandura Bhasma.

Clinical study on the effect of Dadimadi Ghrita and Mandura Bhasma in Pandu Roga (Iron Deficiency Anaemia) - IDA

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/03/008116

Enrollment

Registered

2017-03-16

Start date

Unknown

Completion date

Unknown

Last updated

2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Pandu roga (iron deficiency anemia)

Interventions

Intervention1: Mandura Bhasma Capsule along with Dadimadi Ghrita: Mandura Bhasma Capsule 1 cap (125mg) twice daily orally after food for 2 months. Dadimadi Ghrita 7.5 ml twice daily orally after food

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children of either gender between the age group of 08 to 10 years. 2. Children with hemoglobin percentage between 8 to 12 gm/dl. 3. Parents wiling to give assent for the Research study.

Exclusion criteria

Exclusion criteria: 1. Children with systemic disorders, hemorrhagic diathesis like hemophilia, vitamin k deficiency and Anemia due to other than iron deficiency. 2. Children with concurrent serious hepatic dysfunction and renal dysfunction and uncontrolled pulmonary dysfunction. 3. H/O sensitive to any of the trial drugs

Design outcomes

Primary

Measure	Time frame
Relief in the symptoms of Pandutwa Durbalata Shrama Hridayaspandana Mukhapaka Karnada Shoonakshikuta Aruchi Improvement in Hb gm% MCV RDW Peripheral smearTimepoint: 60days	—

Secondary

Measure	Time frame
Improvement in general health Improvement in school performance Timepoint: 90 days	—

Countries

India

Contacts

Public ContactDr SHAILAJA U

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital

rao.shaila@gmail.com9448816433

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026